Argent Biopharma and Auscann have joined forces in a deal designed to “accelerate cannabinoid-based pharmaceutical development”. […]
Argent Biopharma and Auscann have joined forces in a deal designed to “accelerate cannabinoid-based pharmaceutical development”. […]